Form 4: Vor Biopharma Inc. Executive Amy Quinlan Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Amy Quinlan, Vice President of Finance at Vor Biopharma Inc., reports the disposal of common stock to cover tax withholding obligations related to the settlement of restricted stock units.
Summary
- On August 1, 2024, Amy Quinlan disposed of 343 shares of Vor Biopharma Inc. common stock at a price of $0.94 per share to cover tax obligations.
- On August 6, 2024, she disposed of 206 shares at $0.87 per share for the same reason.
- On September 3, 2024, she disposed of 4,402 shares at $0.83 per share.
- Following these transactions, Quinlan directly owns 50,861 shares of Vor Biopharma Inc. common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions for tax purposes, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure related to stock transactions by a company insider and doesn't necessarily reflect broader industry trends.
Stakeholder Impact
- The transactions have a minimal impact on shareholders as they are related to tax obligations and do not represent a significant change in ownership.
Key Dates
| Date | Description |
|---|---|
| 08/01/2024 | Disposal of 343 shares of common stock at $0.94 per share. |
| 08/06/2024 | Disposal of 206 shares of common stock at $0.87 per share. |
| 09/03/2024 | Disposal of 4,402 shares of common stock at $0.83 per share. |
| 09/04/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.